Study of Tirzepatide for Type 2 Diabetes or Obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new medicine called tirzepatide to see if it helps people with type 2 diabetes or obesity. It is for adults in India who have not used insulin before or meet specific weight and health conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes for at least one year, have never taken insulin, and your average blood sugar (A1C) is between 7.5% and 10%.
- You are overweight or obese without type 2 diabetes, with a BMI of 30 or more, or a BMI of 27 or more along with a weight-related health issue like high blood pressure or sleep apnea.
- You have not had major heart problems (like a heart attack or stroke) in the past 6 months.
- You have not had weight loss surgery or taken weight loss medications in the past 3 months.
- Your weight has not changed by more than 11 pounds (5 kg) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called tirzepatide for people with type 1 diabetes who also have overweight or obesity. Tirzepatide may help with weight loss and blood sugar control, and you'll use a continuous glucose monitor throughout the study.
This study tests if tirzepatide helps people with obesity lose weight, whether or not they have type 2 diabetes. It aims to see how safe and effective the drug is.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
This trial tests the safety and effectiveness of tirzepatide, a once-weekly injection, for weight loss in people with obesity. It might be an option if you have a BMI of 27 or higher with weight-related health problems, or a BMI of 35 or higher, and live in or near Asunción, Paraguay.
This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.